Combined advanced therapies and complex delivery technologies are emerging as innovative medical products due to their contribution to advancing medical care, and are thus expected to have major impact in the coming years. Future technologies are most appealing to patients with ongoing medical conditions who require consistent treatment with daily injections or weekly procedures and who have unmet medical needs. Overall, the successful development of combination products will require great collaboration within the industry to overcome regulatory, clinical, and technical challenges.